Targacept Closes on $30M Stock Offering

Posted: Jan 25, 2008

Winston-Salem, N.C. — Targacept (Nasdaq: TRGT) has wrapped up a stock offering that brought the company more than $30 million.

The biopharmaceutical development firm sold more than 4.37 million shares, with 570,000 of those going to the stock offering’s underwriters.

Deutsche Bank Securities, Lazard Capital Markets LLC, Oppenheimer & Co. Inc. and Pacific Growth Equities, LLC, handled the offering.

Targacept shares closed at $7.08 on Thursday.

Take WRAL.com to go

News Alerts to your Email & Cell Phone

Latest News
- AMD launches Yukon platform for ultraportable computers
  Posted Jan. 6 2:09 p.m.
- Protecting your assets in tough economic times
  Updated Jan. 6 2:01 p.m.
- Start a company in 2009 – Are you nuts? Well, no.
  Posted Jan. 6 1:51 p.m.
- WRAL content now available through iPhone application
  Updated Jan. 6 11:09 a.m. |
- Cisco joins backers for alternative to Microsoft Outlook
  Posted Jan. 6 9:50 a.m.
more |

Venture/Innovation
- Global slowdown could trigger a ‘freeze’ in venture financing, Intersouth partner fears
  Updated Jan. 6 11:34 a.m.
- Atlanta-based Indie Music rolls out popularity tool for musicians
  Posted Jan. 6 6:50 a.m.
- How to survive nuclear winter? Seize the opportunity for success, says veteran S.C. exec
  Jan. 5, 2009
- VentureSource: Worst venture liquidity in five years
  Jan. 3, 2009
- High-tech headsets bring roar of NASCAR racing to videogames
  Jan. 2, 2009
more

Related Items

On The Web

Related Topics

Site Search

Targacept Closes on $30M Stock Offering